Role of anticoagulant therapy in liver disease
- 26 March 2013
- journal article
- review article
- Published by Springer Nature in Hepatology International
- Vol. 7 (2) , 369-376
Abstract
Anticoagulant therapy is a cornerstone in the treatment of different liver diseases. In Budd-Chiari syndrome (BCS), survival rates have increased considerably since the introduction of a treatment strategy in which anticoagulation is the treatment of first choice. In all patients diagnosed with acute portal vein thrombosis (PVT), anticoagulant therapy for at least 3 months is indicated. Anticoagulation should also be considered in patients with chronic PVT and a concurrent prothrombotic risk factor. Current evidence suggests that patients with PVT in cirrhosis will benefit from treatment with anticoagulation as well. In severe chronic liver disease the levels of both pro- and anticoagulant factors are decreased, resetting the coagulant balance in an individual patient and making it more prone to deviate to a hypo- or hypercoagulable state. An increased activity of the coagulation cascade is not solely a feature of chronic liver disease; it influences the development of liver fibrosis as well. Several studies in animals and humans have shown that anticoagulation could prevent or improve fibrogenesis and even disease progression in cirrhosis. Anticoagulation is therefore a promising antifibrotic treatment modality.Keywords
This publication has 78 references indexed in Scilit:
- Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein ThrombosisClinical Gastroenterology and Hepatology, 2012
- The role of hypercoagulability in liver fibrogenesisClinics and Research in Hepatology and Gastroenterology, 2011
- Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutationWorld Journal of Gastroenterology, 2011
- Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver CirrhosisJournal of Clinical Gastroenterology, 2010
- Detection of the Imbalance of Procoagulant Versus Anticoagulant Factors in Cirrhosis by a Simple Laboratory MethodHepatology, 2010
- Vascular disorders of the liver # †Hepatology, 2009
- Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapiesJournal of Thrombosis and Haemostasis, 2008
- Recent Portal or Mesenteric Venous Thrombosis: Increased Recognition and Frequent Recanalization on Anticoagulant TherapyHepatology, 2000
- Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shuntingHepatology, 1999
- Bleeding after liver biopsy does not correlate with indices of peripheral coagulationDigestive Diseases and Sciences, 1981